These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 18367107)

  • 1. The impact of variant histology on the outcome of bladder cancer treated with curative intent.
    Black PC; Brown GA; Dinney CP
    Urol Oncol; 2009; 27(1):3-7. PubMed ID: 18367107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should histologic variants alter definitive treatment of bladder cancer?
    Willis DL; Porten SP; Kamat AM
    Curr Opin Urol; 2013 Sep; 23(5):435-43. PubMed ID: 23880739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urothelial carcinoma with abundant myxoid stroma.
    Tavora F; Epstein JI
    Hum Pathol; 2009 Oct; 40(10):1391-8. PubMed ID: 19535127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
    Paner GP; McKenney JK; Epstein JI; Amin MB
    Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics.
    Shanks JH; Iczkowski KA
    Histopathology; 2009 Jun; 54(7):885-900. PubMed ID: 19178589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
    Liedberg F; Chebil G; Månsson W
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variant histology: role in management and prognosis of nonmuscle invasive bladder cancer.
    Porten SP; Willis D; Kamat AM
    Curr Opin Urol; 2014 Sep; 24(5):517-23. PubMed ID: 24921905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle-invasive urothelial cell carcinoma of the human bladder: multidirectional differentiation and ability to metastasize.
    Domanowska E; Jozwicki W; Domaniewski J; Golda R; Skok Z; Wiśniewska H; Sujkowska R; Wolski Z; Jozwicka G
    Hum Pathol; 2007 May; 38(5):741-6. PubMed ID: 17306328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection.
    Wasco MJ; Daignault S; Zhang Y; Kunju LP; Kinnaman M; Braun T; Lee CT; Shah RB
    Urology; 2007 Jul; 70(1):69-74. PubMed ID: 17656211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upstaging of nonurothelial histology in bladder cancer at the time of surgical treatment in the National Cancer Data Base.
    Cohen AJ; Packiam V; Nottingham C; Steinberg G; Smith ND; Patel S
    Urol Oncol; 2017 Jan; 35(1):34.e1-34.e8. PubMed ID: 27592529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of micropapillary bladder carcinoma].
    Matsumura E; Ashikari A; Tasaki S; Kato S; Ashimine S; Machida N; Toyama H; Oshiro Y; Saito S
    Hinyokika Kiyo; 2012 Jun; 58(6):279-82. PubMed ID: 22874506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma.
    Smaldone MC; Jacobs BL; Smaldone AM; Hrebinko RL
    Urology; 2008 Sep; 72(3):613-6. PubMed ID: 18554696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder.
    Soloway MS; Lee CT; Steinberg GD; Ghandi AA; Jewett MA
    Urol Oncol; 2007; 25(4):338-40. PubMed ID: 17628304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonurothelial bladder cancer and rare variant histologies.
    Willis D; Kamat AM
    Hematol Oncol Clin North Am; 2015 Apr; 29(2):237-52, viii. PubMed ID: 25836932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and therapeutic significance of aberrant differentiation patterns in bladder cancer.
    Black PC; Brown GA; Dinney CP
    Expert Rev Anticancer Ther; 2007 Jul; 7(7):1015-26. PubMed ID: 17627461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specific types of bladder cancer].
    Bertz S; Hartmann A; Knüchel-Clarke R; Gaisa NT
    Pathologe; 2016 Feb; 37(1):40-51. PubMed ID: 26782034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmacytoid urothelial carcinoma of the bladder: a rare malignancy.
    Philippou P; Kariotis I; Volanis D; Ploumides A; Delakas D
    Urol Int; 2011; 86(3):370-2. PubMed ID: 21325783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of histologic homogeneity estimation of muscle-invasive urinary bladder cancer in an individual prognosis: a mapping study.
    Jozwicki W; Domaniewski J; Skok Z; Wolski Z; Domanowska E; Jozwicka G
    Urology; 2005 Nov; 66(5):1122-6. PubMed ID: 16286151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of bladder cancer.
    Sharma S; Ksheersagar P; Sharma P
    Am Fam Physician; 2009 Oct; 80(7):717-23. PubMed ID: 19817342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.